Arkhangelsk Regional Clinical Mental Hospital

Arkhangelsk 163530

0 studies enrolling now · 2 studies all time

What they study most

Depressive Disorder, Major

Studies at this site

• Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age — Stopped early
• Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD) — Completed